While TGF-β-induced Snail expression was consistently inhibited by these drugs, TGF-β-mediated Slug expression was not inhibited by any of the microtubule targeting agents evaluated across a panel of molecularly diverse breast cancer cell lines. Here, TGFB1 is linked to breast carcinoma.